Therapeutic response to benzodiazepine in panic disorder subtypes

Bibliographic Details
Main Author: Valença,Alexandre Martins
Publication Date: 2003
Other Authors: Nardi,Antonio Egidio, Mezzasalma,Marco André, Nascimento,Isabella, Zin,Walter Araújo, Lopes,Fabiana Leão, Versiani,Marcio
Format: Article
Language: eng
Source: São Paulo medical journal (Online)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802003000200009
Summary: CONTEXT: This study makes a comparison between two subtypes of panic disorder regarding the clinical efficacy of clonazepam, a benzodiazepine. OBJECTIVES: To evaluate the clinical efficacy of clonazepam in a fixed dosage (2 mg/day), compared to placebo, in the treatment of panic disorder patients and to verify whether there are any differences in the responses to clonazepam between panic disorder patients with the respiratory and non-respiratory subtypes. TYPE OF STUDY: Randomized study with clonazepam and placebo. SETTING: Outpatient Anxiety and Depression Unit of the Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. PARTICIPANTS: 34 patients with a diagnosis of panic disorder with agoraphobia, between 18 and 55 years old. PROCEDURES: Administration of clonazepam or placebo for 6 weeks, in panic disorder patients, after they were classified within two subtypes of panic disorder: respiratory and non-respiratory. MAIN MEASUREMENTS: Changes in the number of panic attacks in comparison with the period before the beginning of the study; Hamilton Anxiety Scale; Global Clinical Impression Scale; and Patient's Global Impression scale. RESULTS: In the group that received clonazepam, by the end of the 6th week there was a statistically significant clinical improvement, shown by the remission of panic attacks (p < 0.001) and decrease in anxiety (p = 0.024). In the group that received clonazepam there was no significant difference between the respiratory and non-respiratory subtypes of panic disorder, regarding the therapeutic response to clonazepam. CONCLUSION: Clonazepam was equally effective in the treatment of the respiratory and non-respiratory subtypes of panic disorder, suggesting there is no difference in the therapeutic response between the two subtypes.
id APM-1_fb87f69f34fc12906f4e76bf327966a5
oai_identifier_str oai:scielo:S1516-31802003000200009
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Therapeutic response to benzodiazepine in panic disorder subtypesTreatmentPanicDisorderSubtypeRespirationClonazepamCONTEXT: This study makes a comparison between two subtypes of panic disorder regarding the clinical efficacy of clonazepam, a benzodiazepine. OBJECTIVES: To evaluate the clinical efficacy of clonazepam in a fixed dosage (2 mg/day), compared to placebo, in the treatment of panic disorder patients and to verify whether there are any differences in the responses to clonazepam between panic disorder patients with the respiratory and non-respiratory subtypes. TYPE OF STUDY: Randomized study with clonazepam and placebo. SETTING: Outpatient Anxiety and Depression Unit of the Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. PARTICIPANTS: 34 patients with a diagnosis of panic disorder with agoraphobia, between 18 and 55 years old. PROCEDURES: Administration of clonazepam or placebo for 6 weeks, in panic disorder patients, after they were classified within two subtypes of panic disorder: respiratory and non-respiratory. MAIN MEASUREMENTS: Changes in the number of panic attacks in comparison with the period before the beginning of the study; Hamilton Anxiety Scale; Global Clinical Impression Scale; and Patient's Global Impression scale. RESULTS: In the group that received clonazepam, by the end of the 6th week there was a statistically significant clinical improvement, shown by the remission of panic attacks (p < 0.001) and decrease in anxiety (p = 0.024). In the group that received clonazepam there was no significant difference between the respiratory and non-respiratory subtypes of panic disorder, regarding the therapeutic response to clonazepam. CONCLUSION: Clonazepam was equally effective in the treatment of the respiratory and non-respiratory subtypes of panic disorder, suggesting there is no difference in the therapeutic response between the two subtypes.Associação Paulista de Medicina - APM2003-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802003000200009Sao Paulo Medical Journal v.121 n.2 2003reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/S1516-31802003000200009info:eu-repo/semantics/openAccessValença,Alexandre MartinsNardi,Antonio EgidioMezzasalma,Marco AndréNascimento,IsabellaZin,Walter AraújoLopes,Fabiana LeãoVersiani,Marcioeng2003-07-14T00:00:00Zoai:scielo:S1516-31802003000200009Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2003-07-14T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Therapeutic response to benzodiazepine in panic disorder subtypes
title Therapeutic response to benzodiazepine in panic disorder subtypes
spellingShingle Therapeutic response to benzodiazepine in panic disorder subtypes
Valença,Alexandre Martins
Treatment
Panic
Disorder
Subtype
Respiration
Clonazepam
title_short Therapeutic response to benzodiazepine in panic disorder subtypes
title_full Therapeutic response to benzodiazepine in panic disorder subtypes
title_fullStr Therapeutic response to benzodiazepine in panic disorder subtypes
title_full_unstemmed Therapeutic response to benzodiazepine in panic disorder subtypes
title_sort Therapeutic response to benzodiazepine in panic disorder subtypes
author Valença,Alexandre Martins
author_facet Valença,Alexandre Martins
Nardi,Antonio Egidio
Mezzasalma,Marco André
Nascimento,Isabella
Zin,Walter Araújo
Lopes,Fabiana Leão
Versiani,Marcio
author_role author
author2 Nardi,Antonio Egidio
Mezzasalma,Marco André
Nascimento,Isabella
Zin,Walter Araújo
Lopes,Fabiana Leão
Versiani,Marcio
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Valença,Alexandre Martins
Nardi,Antonio Egidio
Mezzasalma,Marco André
Nascimento,Isabella
Zin,Walter Araújo
Lopes,Fabiana Leão
Versiani,Marcio
dc.subject.por.fl_str_mv Treatment
Panic
Disorder
Subtype
Respiration
Clonazepam
topic Treatment
Panic
Disorder
Subtype
Respiration
Clonazepam
description CONTEXT: This study makes a comparison between two subtypes of panic disorder regarding the clinical efficacy of clonazepam, a benzodiazepine. OBJECTIVES: To evaluate the clinical efficacy of clonazepam in a fixed dosage (2 mg/day), compared to placebo, in the treatment of panic disorder patients and to verify whether there are any differences in the responses to clonazepam between panic disorder patients with the respiratory and non-respiratory subtypes. TYPE OF STUDY: Randomized study with clonazepam and placebo. SETTING: Outpatient Anxiety and Depression Unit of the Institute of Psychiatry, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. PARTICIPANTS: 34 patients with a diagnosis of panic disorder with agoraphobia, between 18 and 55 years old. PROCEDURES: Administration of clonazepam or placebo for 6 weeks, in panic disorder patients, after they were classified within two subtypes of panic disorder: respiratory and non-respiratory. MAIN MEASUREMENTS: Changes in the number of panic attacks in comparison with the period before the beginning of the study; Hamilton Anxiety Scale; Global Clinical Impression Scale; and Patient's Global Impression scale. RESULTS: In the group that received clonazepam, by the end of the 6th week there was a statistically significant clinical improvement, shown by the remission of panic attacks (p < 0.001) and decrease in anxiety (p = 0.024). In the group that received clonazepam there was no significant difference between the respiratory and non-respiratory subtypes of panic disorder, regarding the therapeutic response to clonazepam. CONCLUSION: Clonazepam was equally effective in the treatment of the respiratory and non-respiratory subtypes of panic disorder, suggesting there is no difference in the therapeutic response between the two subtypes.
publishDate 2003
dc.date.none.fl_str_mv 2003-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802003000200009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802003000200009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-31802003000200009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Paulista de Medicina - APM
publisher.none.fl_str_mv Associação Paulista de Medicina - APM
dc.source.none.fl_str_mv Sao Paulo Medical Journal v.121 n.2 2003
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1754209260512739328